Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of the Thoracoabdominal and Pararenal Aortic Aneurysms (TAMBE)
NCT ID: NCT05442489
Last Updated: 2025-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
APPROVED_FOR_MARKETING
EXPANDED_ACCESS
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study
NCT06578741
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms
NCT02528500
TAMBE Japan Post-Marketing Surveillance
NCT07147569
Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms
NCT00590759
Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
NCT02777593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GORE Excluder Thoracoabdominal Branch Endoprosthesis
TEVAR
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* An Informed Consent Form signed by Subject or legal representative
* Appropriate aortic anatomy to receive the TAMBE Device d
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
W.L.Gore & Associates
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Mayo Clinic Arizona
Scottsdale, Arizona, United States
Keck Medical Center of USC
Los Angeles, California, United States
Kaiser Permanente San Francisco Medical Center
San Francisco, California, United States
Stanford University
Stanford, California, United States
MedStar Health Research Institute - MedStar Washington Hospital
Washington D.C., District of Columbia, United States
University of Florida - Gainesville
Gainesville, Florida, United States
University of South Florida
Tampa, Florida, United States
Emory University Hospital
Atlanta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
University of Michigan - Cardiac Surgery
Ann Arbor, Michigan, United States
Essentia Health
Duluth, Minnesota, United States
Division of Vascular Surgery - Minneapolis Heart Institute
Minneapolis, Minnesota, United States
Mayo Clinic - Rochester
Rochester, Minnesota, United States
Washington University School of Medicine
St Louis, Missouri, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Mount Sinai West
New York, New York, United States
Weill Cornell Medical Center
New York, New York, United States
University of Rochester
Rochester, New York, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Sanger Heart & Vascular Institute
Charlotte, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States
Cleveland Clinic
Cleveland, Ohio, United States
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
UPP Heart and Vascular Institute
Pittsburgh, Pennsylvania, United States
University of Tennessee -University Vascular Surgeons
Knoxville, Tennessee, United States
St. David's Healthcare
Austin, Texas, United States
Baylor Heart & Vascular Hospital
Dallas, Texas, United States
University of Texas Southwestern
Dallas, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
The Methodist Hospital - Houston
Houston, Texas, United States
University of Texas Health Science Center
Houston, Texas, United States
Sentara Medical Group
Norfolk, Virginia, United States
Carilion Clinic Hospitals
Roanoke, Virginia, United States
University of Washington
Seattle, Washington, United States
University of Wisconsin - Madison
Madison, Wisconsin, United States
Aurora Health Care, Metro Inc.
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAA 17-01 Expanded Access
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.